Prevalence of Metabolic-Associated Steatohepatitis (MASH) and Advanced Fibrosis in At-Risk Pediatric Populations

被引：0
|
作者：
Kim, Yestle [1 ]
Charlton, Michael [2 ]
Rezvani, Geoff [1 ]
Saal, Gauri B. [3 ]
机构：
[1] Madrigal Pharmaceut, Conshohocken, PA USA
[2] Univ Chicago Med, Chicago, IL USA
[3] Neulum Consulting, Solihull, England
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036672.48353.6c
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1826
引用
收藏
页码：S1316 / S1317
页数：2
相关论文
共 50 条
  • [31] ACUTE PANCREATITIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES?
    Kim, Do Han
    Ko, Donghyun
    Corral, Juan E.
    Kroner, Paul T.
    Lukens, Frank
    Argueta, Pedro Palacios
    GASTROENTEROLOGY, 2024, 166 (05) : S1663 - S1664
  • [32] NIS2+®, AN EFFECTIVE TOOL FOR MONITORING MASH RESOLUTION AND FIBROSIS IMPROVEMENT IN PATIENTS WITH AT-RISK MASH
    Sanyal, Arun
    Ratziu, Vlad
    Hajji, Yacine
    Magnanensi, Jeremy
    Majd, Zouher
    Hum, Dean
    Staels, Bart
    Connelly, Margery
    Francque, Sven
    Anstee, Quentin
    HEPATOLOGY, 2024, 80 : S610 - S611
  • [33] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
  • [34] Non-alcoholic steatohepatitis or metabolic-associated fatty liver: time to change
    Shiha, Gamal
    Mousa, Nasser
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (01) : 123 - 125
  • [35] Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9
    Xin, Xin
    Chen, Cheng
    Xu, Xiao
    Lv, Sheng
    Sun, Qinmei
    An, Ziming
    Chen, Yi
    Xiong, Zhekun
    Hu, Yiyang
    Feng, Qin
    REDOX BIOLOGY, 2025, 80
  • [36] METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): UNDERLYING MECHANISMS AND DIAGNOSTIC AND THERAPEUTIC ADVANCES
    Mantzoros, Christos S.
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 218 : 2 - 2
  • [37] Increasing Number of Metabolic Co-Morbidities are Associated with Higher Risk of Advanced Fibrosis in Patients with Non-alcoholic Steatohepatitis
    Wong, Robert
    Tram Tran
    Kaufman, Harvey
    Niles, Justin
    Gish, Robert G.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E160 - E160
  • [38] INCREASED RISK OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE AND LIVER FIBROSIS IN INFLAMMATORY BOWEL DISEASE INDEPENDENT OF CLASSIC METABOLIC RISK FACTORS
    Rodriguez Duque, Juan Carlos
    Iruzubieta, Paula
    Rivas, Coral
    Jose Garcia, Maria
    Pascual, Marta
    Castro, Beatriz
    Garcia, Agustin
    Garcia-Nieto, Enrique
    Curiel, Soraya
    Luisa Cagigal, Maria
    Lopez-Montejo, Lorena
    Fernandez, Tatiana
    Rasines, Laura
    Ignacio Fortea, Jose
    Pedro Vague, Jose
    Rivero, Monserrat
    Teresa Arias, Maria
    Crespo Garcia, Javier
    HEPATOLOGY, 2020, 72 : 975 - 976
  • [39] SEPSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES AND HIGHER MORTALITY?
    Kim, Do Han
    Ko, Donghyun
    Argueta, Pedro Palacios
    Kroner, Paul T.
    Lukens, Frank
    Corral, Juan E.
    GASTROENTEROLOGY, 2024, 166 (05) : S1661 - S1662
  • [40] Metabolic issues in patients with metabolic dysfunction-associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review
    Alnimer, Lynna
    Arellano, Diego
    Brombosz, Elizabeth
    Noureddin, Mazen
    LIVER TRANSPLANTATION, 2024,
12345